11
Total investments
4
Early stage
2
Mid stage
3
Late stage
11y
Years active
Portfolio
10 investments · sorted by recency
All investments
Early stage
Mid stage
Late stage
Private Investor
Jun 2022
Sanctuary Health are leaders in ready-to-use patient education content.
Our content is designed with accessibility, engagement and clinical accuracy top to mind, inspiring millions of people to live healthier lives.
Executive Board Member
Apr 2020
ScubaTx is developing a new breakthrough platform for the preservation of human organs.
Private Investor
Jan 2019
Cydar Medical is a global cloud-based software company that provides an integrated solution for planning, navigation and review of surgical procedures powered by Artificial Intelligence.
As leaders in our field, our mission is to transform the way information is provided to clinicians at every stage of the patient pathway to inform better clinical decision-making.
We believe that our clinicians should have the world’s experience at their fingertips, and we will help achieve this vision by using the latest cutting-edge AI technology to enable them to make faster, easier, and safer decisions.
Our first product, Cydar EV Maps, is in use in leading centers across the globe. The system generates a patient-specific 3D map of relevant soft tissue that updates real-time to optimise procedure planning and intra-operative navigation as well as allowing assessment of outcomes. The AI will learn from all procedures globally to provide predictive analytics to assist our clinicians in the OR.
Private Investor
Aug 2017
ContentCal is now part of Adobe Express, available on mobile, web, and desktop. Start for free today.
Private Investor
Apr 2017
emoquo is a unique emotional intelligence platform.
We deliver digital coaching and people analytics solutions for organisations who want to increase the engagement, wellbeing and performance of their people.
Private Investor
Apr 2017
Transforming Employee Engagement - Reaching and engaging your entire workforce.
StaffConnect delivers a powerful mobile employee engagement platform that transforms the employee experience by enabling large enterprises to connect, communicate and engage their entire workforce, especially remote, non-desk employees.
The customer-branded mobile app gives employees ‘a voice’, with access to company and user-generated content to increase loyalty and productivity. The cloud-hosted platform empowers employers to target that content, with analytics, to deepen engagement with everyone.
From offices in London and San Francisco, StaffConnect’s platform and domain experts are supporting large businesses from around the world to inspire their workforces to deliver better performance, improved customer experiences and greater shareholder value.
Private Investor
Nov 2016
Cold Brew Coffee from London, UK.
Sandows London specialises in cold brew coffee. We use our coffee industry experience to make the best cold brew possible – coffee brewed using cold water. Cold brewing extracts a noticeably smoother, naturally sweet flavour. Whereas pouring hot espresso over ice throws everything out of balance resulting in a watery, bitter drink; cold brew is gently steeped using soft water to slowly drag out more flavour - making for delicious, black iced coffee! Our premium quality coffee with low acidity that looks beautiful and also contains no sugar, very few calories (under 12) and is suitable for all diets.
Private Investor
Dec 2015
We are an innovative Scottish biotechnology company developing novel therapeutic antibody approaches to target a fundamental control pathway associated with several major diseases. These novel approaches give aTen Therapeutics the potential to develop powerful new treatments to extend and improve lives.
aTen Therapeutics Ltd (registered in Scotland no 547221) is a wholly-owned subsidiary of OncoBioPharm Limited (registered in Scotland 29/7/05 no. SC288225).
Private Investor
Dec 2015
Medannex is an award-winning Scottish biopharmaceutical company committed to unlocking the therapeutic potential of targeting annexin-A1. Our goal is to create a first-in-class therapy to improve the lives of people impacted by cancers and autoimmune diseases. Following a recent Series B fundraise, and supported by both the Scottish Investment Bank and Innovate UK, Medannex is collaborating with world-leading clinical experts to explore the huge therapeutic and commercial potential of our patent-protected immunomodulatory technology.
Private Investor
Apr 2015
Harnessing an innate mechanism of gene activation, MiNA Therapeutics' platform enables the development of new medicines that restore normal function to patients’ cells. We are applying our technology and clinical know-how to transform the therapy landscape of severe liver and other diseases.
Experience · 15 entries
All (15)
Investments (11)
Founder (3)
Board (1)
2022
Private Investor
Jun 2022
Sanctuary Health are leaders in ready-to-use patient education content.
Our content is designed with accessibility, engagement and clinical accuracy top to mind, inspiring millions of people to live healthier lives.
Co-Founder COO
Feb 2022
vTail Dental is a mobile-first platform supporting dental teams by giving them super simple access to dental product companies.
2020
V
vTail Healthcare Telecommunications
Co-Founder
Jun 2020
Executive Board Member
Apr 2020
ScubaTx is developing a new breakthrough platform for the preservation of human organs.
2019
Private Investor
Jan 2019
Cydar Medical is a global cloud-based software company that provides an integrated solution for planning, navigation and review of surgical procedures powered by Artificial Intelligence.
As leaders in our field, our mission is to transform the way information is provided to clinicians at every stage of the patient pathway to inform better clinical decision-making.
We believe that our clinicians should have the world’s experience at their fingertips, and we will help achieve this vision by using the latest cutting-edge AI technology to enable them to make faster, easier, and safer decisions.
Our first product, Cydar EV Maps, is in use in leading centers across the globe. The system generates a patient-specific 3D map of relevant soft tissue that updates real-time to optimise procedure planning and intra-operative navigation as well as allowing assessment of outcomes. The AI will learn from all procedures globally to provide predictive analytics to assist our clinicians in the OR.
Show all 15 entries ↓
Investment activity
2015–2022 · 11 investments
Recent (last 2 years)Earlier
